297 related articles for article (PubMed ID: 23514331)
1. Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.
Gallo P; Cecchi PC; Locatelli F; Rizzo P; Ghimenton C; Gerosa M; Pinna G
Br J Neurosurg; 2013 Dec; 27(6):759-64. PubMed ID: 23514331
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
[TBL] [Abstract][Full Text] [Related]
3. Temporal lobe pleomorphic xanthoastrocytoma and chronic epilepsy: long-term surgical outcomes.
Wallace DJ; Byrne RW; Ruban D; Cochran EJ; Roh D; Whisler WW
Clin Neurol Neurosurg; 2011 Dec; 113(10):918-22. PubMed ID: 21741164
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of prognostic factors on survival in patients with low grade glioma.
Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
[TBL] [Abstract][Full Text] [Related]
5. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
[TBL] [Abstract][Full Text] [Related]
6. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
[TBL] [Abstract][Full Text] [Related]
8. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
9. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
Marton E; Feletti A; Orvieto E; Longatti P
J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic xanthoastrocytoma in children and adolescents.
Rao AA; Laack NN; Giannini C; Wetmore C
Pediatr Blood Cancer; 2010 Aug; 55(2):290-4. PubMed ID: 20582976
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic xanthoastrocytoma: what do we really know about it?
Giannini C; Scheithauer BW; Burger PC; Brat DJ; Wollan PC; Lach B; O'Neill BP
Cancer; 1999 May; 85(9):2033-45. PubMed ID: 10223246
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.
Tabouret E; Bequet C; Denicolaï E; Barrié M; Nanni I; Metellus P; Dufour H; Chinot O; Figarella-Branger D
Eur J Surg Oncol; 2015 Dec; 41(12):1685-90. PubMed ID: 26454767
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas.
Waqar M; Hanif S; Brodbelt AR; Rathi N; Das K; Zakaria R; Walker C; Jenkinson MD
World Neurosurg; 2015 Jul; 84(1):154-62. PubMed ID: 25779854
[TBL] [Abstract][Full Text] [Related]
15. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.
Majchrzak K; Kaspera W; Bobek-Billewicz B; Hebda A; Stasik-Pres G; Majchrzak H; Ładziński P
Clin Neurol Neurosurg; 2012 Oct; 114(8):1135-44. PubMed ID: 22425370
[TBL] [Abstract][Full Text] [Related]
16. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic xanthoastrocytomas: institutional experience of 18 patients.
Oh T; Kaur G; Madden M; Bloch O; Parsa AT
J Clin Neurosci; 2014 Oct; 21(10):1767-72. PubMed ID: 24950906
[TBL] [Abstract][Full Text] [Related]
18. Grade II Pleomorphic Xanthoastrocytoma; a meta-analysis of data from previously reported 167 cases.
Mallick S; Benson R; Melgandi W; Giridhar P; Rath GK
J Clin Neurosci; 2018 Aug; 54():57-62. PubMed ID: 29803334
[TBL] [Abstract][Full Text] [Related]
19. [Pleomorphic xanthoastrocytoma: clinical symptoms, treatment, outcome].
Majchrzak K; Bierzyńska-Macyszyn G; Ładziński P
Neurol Neurochir Pol; 2003; 37(3):611-9. PubMed ID: 14593756
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients.
Ahmadi R; Dictus C; Hartmann C; Zürn O; Edler L; Hartmann M; Combs S; Herold-Mende C; Wirtz CR; Unterberg A
Acta Neurochir (Wien); 2009 Nov; 151(11):1359-65. PubMed ID: 19575144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
